Albumin Dialysis MARS: Knowledge from 10 Years of Clinical Investigation

@article{Mitzner2009AlbuminDM,
  title={Albumin Dialysis MARS: Knowledge from 10 Years of Clinical Investigation},
  author={Steffen R. Mitzner and Jan Stange and Sebastian Klammt and Sebastian Koball and Heiko Hickstein and Emil C Reisinger},
  journal={ASAIO Journal},
  year={2009},
  volume={55},
  pages={498-502}
}
A decade ago, albumin dialysis was introduced as a new extracorporeal detoxification method for patients with liver failure. Today, the molecular adsorbent recirculating system is the most frequently used type of albumin dialysis and most studied liver-support technique. Numerous preclinical and clinical studies demonstrated the importance of albumin as a scavenger for molecules with pathophysiological relevance in liver failure. Albumin dialysis enables the selective regeneration of albumin… 
Stability of therapeutic albumin solutions used for molecular adsorbent recirculating system-based liver dialysis.
TLDR
In vitro results suggest limited direct influence of the presence of stabilizers in therapeutic albumin solutions on baseline binding properties of human albumin, but in vitro incubations of these albumins for several hours resulted in supplier-specific changes in warfarin binding, suggesting an influence of stabilizer on the stability of binding properties.
Comparison of albumin dialysis devices molecular adsorbent recirculating system and ADVanced Organ Support system in critically ill patients with liver failure—A retrospective analysis
TLDR
In cycles with similar treatment times, both systems provided comparable reduction rates for bilirubin, renal replacement, coagulation, and metabolic parameters, and Citrate was the preferred anticoagulant in case of bleeding.
Extracorporal methods for liver failure treatment
TLDR
Currently, MARS is a promising trend of liver failure treatment, as it allows support the liver function for a long time until restored or an optimal donor will be found.
Albumin in Artificial Liver Support Systems
While liver transplantation is the only accepted therapy for liver failure, bound solute dialysis (BSD) may provide an alternative. Current BSD methods, MARS and SPAD, are unfortunately poorly
Acute-on-chronic liver failure: extracorporeal liver assist devices
TLDR
Liver support systems are safe and well tolerated when used in management of patients with ACLF and should continue in controlled clinical trials to explore their role in bridging patients to liver transplantation or recovery in well defined patient groups.
Experience with molecular adsorbent recirculating system treatment in 20 children listed for high‐urgency liver transplantation
  • W. Lexmond, C. V. van Dael, +5 authors M. Kömhoff
  • Medicine
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2015
TLDR
The data demonstrate the safety of MARS even in the most severely ill patients awaiting LT, but strategies that promote the more rapid and widespread availability of high‐quality donor organs remain of critical importance for improving patient survival in cases of severe acute liver failure.
Bridging Therapies and Liver Transplantation in Acute Liver Failure; 10 Years of MARS Experience from Finland
TLDR
Better prognostic markers than hepatic encephalopathy should be used to assess the need for liver transplantation in acute liver failure, especially in patients with a completely necrotic liver.
Molecular Adsorbent Recirculating System Can Reduce Short-Term Mortality Among Patients With Acute-on-Chronic Liver Failure—A Retrospective Analysis*
TLDR
Molecular adsorbent recirculating system treatment was associated with an improved short-term survival of patients with acute-on-chronic liver failure and multiple organ failure, and was particularly evident among patients with increased kidney, brain, or coagulation Chronic Liver Failure-C-Organ Failure subscores.
Acute liver failure: current practice and recent advances.
TLDR
Routine use of NAC is recommended for patients with early hepatic encephalopathy, irrespective of the etiology, and the role of hypothermia remains to be determined.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 68 REFERENCES
Albumin dialysis: an update
  • S. Mitzner
  • Medicine
    Current opinion in nephrology and hypertension
  • 2007
TLDR
Albumin regeneration has developed into a central component of modern liver support technologies and is the most frequently used and best studied liver support technique at present time.
Drug Insight: the role of albumin in the management of chronic liver disease
  • F. Wong
  • Medicine
    Nature Clinical Practice Gastroenterology &Hepatology
  • 2007
TLDR
The latest indication for albumin use in cirrhotic patients is extracorporeal albumin dialysis, which has shown promise for the treatment of hepatic encephalopathy; its role in hepatorenal syndrome or acute on chronic liver failure has not been established.
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial
  • S. Mitzner, J. Stange, +14 authors R. Schmidt
  • Medicine
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2000
TLDR
It is concluded that the removal of albumin‐bound substances with the MARS method can contribute to the treatment of type I HRS.
Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
TLDR
It is concluded that the molecular adsorbent recirculating system can contribute to the treatment of critically ill patients with liver failure and different underlying diseases.
THE EFFECT OF ALBUMIN DIALYSIS ON CYTOKINE LEVELS IN ACUTE LIVER FAILURE AND NEED FOR LIVER TRANSPLANTATION
TLDR
In theory, MARS albumin dialysis may remove toxic substances from the blood circulation and thereby improve the possibilities of the liver to recover; however, of the measured cytokines only IL-10 decreased significantly, which in this setting could be interpreted as a positive effect.
Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation
TLDR
A statistically significant improvement of liver function was observed after MARS therapy, andTransplant-free recovery was more frequent than expected and the apparent benefit of MARS dialysis to treat acute liver failure needs to be confirmed by a controlled study.
Improvement of impaired albumin binding capacity in acute‐on‐chronic liver failure by albumin dialysis
  • S. Klammt, S. Mitzner, +5 authors R. Schmidt
  • Medicine
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2008
TLDR
Characterization of albumin function by the ABiC test may help to evaluate different liver support systems and other therapeutic measures and the beneficial effect of this treatment may be related to the improvement ofalbumin binding function more than to the elimination of specific substances.
First Use of the Molecular Adsorbent Recirculating System Technique on Patients with Hypoxic Liver Failure After Cardiogenic Shock
TLDR
It is concluded that despite the limited number of patients included in this analysis, MARS can be recommended for patients with acute, hypoxic liver failure because it might prolong survival.
Improvement in Central Nervous System Functions During Treatment of Liver Failure with Albumin Dialysis MARS—A Review of Clinical, Biochemical, and Electrophysiological Data
TLDR
In conclusion, MARS significantly improves central nervous system functions and can serve as a model for the further investigation of the role of protein-bound substances in hepatic encephalopathy and cerebral hemodynamics.
Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study
TLDR
ECAD appears to be effective and safe for the short‐term treatment of patients with cirrhosis and superimposed acute injury associated with progressive hyperbilirubinemia and may be useful for increasing survival in such patients awaiting liver transplantation.
...
1
2
3
4
5
...